Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes

NATerminatedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

September 6, 2019

Primary Completion Date

June 12, 2020

Study Completion Date

June 12, 2020

Conditions
Diabetes Mellitus, Type 2
Interventions
DEVICE

BD Diabetes Care Application (for mobile devices) PLUS use of BD Nano Pen Needle

Subjects in the Intervention Group will be instructed to use the DC-App and switch from their current pen needle to the BD Nano 2nd Gen Pen needle during their participation in the study. The app is intended to be used as a patient education tool and data logger to augment the diabetes care team.

Trial Locations (4)

33401

Metabolic Research Institute, West Palm Beach

78749

Texas Diabetes and Endocrinology, Austin

94401

Mills Pennisula Medical Center-Diabetes Research Institute, San Mateo

96814

East West Medical Research Institute, Honolulu

Sponsors
All Listed Sponsors
lead

Becton, Dickinson and Company

INDUSTRY